Skip to content
healthcare.dev

Tembexa

NDC 64678-012, Brincidofovir, suspension, from Emergent BioDefense Operations Lansing LLC.

Product NDC
64678-012
Status
Listed
Labeler
Emergent BioDefense Operations Lansing LLC
Dosage form
SUSPENSION
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA214460
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/64678-012 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • BRINCIDOFOVIR10 mg/mL
Package NDCNDC-11Package
64678-012-016467800120165 mL in 1 BOTTLE (64678-012-01)
64678-012-026467800120265 mL in 1 BOTTLE (64678-012-02)
64678-012-03646780012031 BOTTLE in 1 CARTON (64678-012-03) / 45 mL in 1 BOTTLE
64678-012-04646780012041 BOTTLE in 1 CARTON (64678-012-04) / 45 mL in 1 BOTTLE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/0784838e-00bd-4b14-9b7e-653b7fbb7eea

Use it

Look up 64678-012 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/64678-012 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 64678-012. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.